Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOI, etc.
Macrophages with high expression of triggering receptor expressed on myeloid cell 2 (TREM2) constitute a specialized macrophage subset residing in atherosclerotic plaques, which is distinguished by potent lipid processing and metabolic adaptive phenotypes. Accumulating evidence indicates that TREM2 does not exert a purely pro-atherogenic or anti-atherogenic role in atherosclerosis; instead, it elicits disparate regulatory effects on plaque burden and plaque composition. On one hand, TREM2 facilitates lipid uptake, preserves the survival and in situ proliferation of foam macrophages, and consequently elevates plaque burden. On the other hand, it boosts macrophage metabolic fitness and efferocytosis, inhibits the development of necrotic cores, and facilitates plaque remodeling. The simultaneous presentation of aggravated plaque burden and ameliorated plaque stability unveils the dual functional property of TREM2 during atherogenesis. This review elaborates on the molecular mechanisms underlying TREM2 signaling, the unique phenotypes of TREM2-high macrophages, as well as their modulatory functions in plaque burden and composition, so as to offer theoretical references for mechanistic exploration and targeted therapeutic strategies against atherosclerosis.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Comments on this article